
Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 15
Selected: 0
NCT ID | Title | ||
---|---|---|---|
NCT06640166 | Encorafenib + Cetuximab Beyond Progression in Combination With FOLFIRI in Patients With BRAF V600E Mutated Metastatic Colorectal Cancer Progressing on Encorafenib + Cetuximab. | ||
NCT03007992 | Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer | ||
NCT04045691 | Binimetinib Plus Encorafenib Real Life Investigation of Next Generation Melanoma Treatment | ||
NCT01103544 | JAVLOR® Online Non-Interventional Trial | ||
NCT02619929 | Initial Oral Vinorelbine Dosing Schedules in Clinical Routine in Germany and Austria | ||
NCT04673955 | BRAF Inhibitor Encorafenib And Cetuximab Real Life Investigation of Next Generation CRC Treatment | ||
NCT05510895 | Neoadjuvant Encorafenib, Binimetinib and Cetuximab for Patients With BRAF V600E Mutated/pMMR Localized Colorectal Cancer | ||
NCT00683514 | Oral Chemotherapy And Platinum With Radiotherapy Followed Or Not By Consolidation With The Same Chemotherapy In Locally Advanced Non Small Cell Lung Cancer | ||
NCT04388384 | Real-life Pan-HER-blockade With Neratinib | ||
NCT00890903 | Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC) | ||
NCT06422715 | PTLD: Multicentric Retrospective Study | ||
NCT03848052 | Evolution of the Therapeutic Care in Lung Cancer in France Since 2015 (ESME LC) | ||
NCT03275311 | Evolution of the Therapeutic Care in Metastatic Breast Cancer From 2008 | ||
NCT04318405 | Real Life Study on Iron Isomaltoside 1000 in the Treatment of ID in CKD, Heart Failure, ObGyn, IBD, Cancer and Elective Surgery (Real-CHOICE). | ||
NCT00168883 | Study for Patients With Non Small Cell Lung Cancer (NSCLC) |